James Cancer Hospital, Ohio State University
Columbus, Ohio, United States
Dr. Kami Maddocks is a Professor of Clinical Internal Medicine and Director of the Lymphoma Program in the Division of Hematology at The Ohio State University. She specializes in treating patients with B-cell lymphomas. Dr. Maddocks conducts research evaluating new-targeted therapies for these lymphomas, with a particular interest in mantle cell lymphoma and diffuse large B cell lymphoma.
Dr. Maddocks is an investigator on several clinical trials in lymphoma, evaluating non-chemotherapeutic approaches to the treatment of lymphoma and the role of minimal residual disease in predicting outcomes and making therapeutic decisions. She serves on the Alliance Lymphoma Committee, ASH Subcommittee on Clinical Trials and just completed a term as LFR LSRMP Co-Chair. She enjoys interacting with and treating patients and over the years has been very involved with philanthropic efforts.
Session VII: T Cell and Hodgkin Lymphomas, and New Ways of Targeting BTK
Thursday, October 19, 2023
1:10 PM – 3:30 PM ET
BTK Inhibitors for B Cell Lymphomas – Does It Matter Which One You Choose?
Thursday, October 19, 2023
2:50 PM – 3:10 PM ET
Panel Discussion and Post-Session Audience Survey
Thursday, October 19, 2023
3:10 PM – 3:30 PM ET